Sign In
Buy LLY
$1,185.71
-7.09 (-0.594%)
At Close: Aug 07, 2026
Top 7 Contenders to Join the Trillion-Dollar Club
01:54pm, Tuesday, 20'th Feb 2024
By hitting the elusive $3 trillion mark in valuation last month, Microsoft (NASDAQ: MSFT ) reignited the debate over trillion-dollar companies. This monumental achievement, fueled by the burgeoning
5 Best-Performing S&P 500 Stocks Halfway Through Q1
09:11am, Tuesday, 20'th Feb 2024
Nvidia (NVDA), Eli Lilly (LLY), Meta Platforms (META), Uber Technologies (UBER) and Ralph Lauren (RL) are the five best-performing stocks in the S&P 500.
These stocks are overbought and may crash soon
04:28am, Tuesday, 20'th Feb 2024
During the holiday period, stock markets experienced a lull with minimal activity. However, certain stocks garnered investor attention, pushing them into the ‘overbought' territory, potentially pavi
EU drug regulator to review Lilly's Mounjaro in multi-dose pen
09:09am, Monday, 19'th Feb 2024
The European Union's healthcare regulator will this week review the use of Eli Lilly's approved Mounjaro drug against diabetes and obesity when prefilled in a multi-dose injection pen, according to a
3 Stocks Primed to Reach Trillion-Dollar Valuation
06:21am, Monday, 19'th Feb 2024
With the coveted trillion-dollar valuation, a new pinnacle of success is approaching for a limited number of companies. This once-impossible milestone is now within reach for three formidable potentia
Where Will Eli Lilly Be in 5 Years?
01:45am, Sunday, 18'th Feb 2024
Its core therapeutic area will be a major tailwind in the next five years. The drugmaker should make significant progress in other fields, too.
Why Eli Lilly is a top pick to capitalize on GLP-1 drug craze
06:29pm, Friday, 16'th Feb 2024
As the craze surrounding weight loss drugs like GLP-1s continues, many investors are wondering how to capitalize on the massive valuation given to this sector by many on Wall Street. Matt Higgins, RSE
Calls of the Day: Trade Desk, Eli Lilly and Palo Alto Networks
01:45pm, Friday, 16'th Feb 2024
The “Halftime Report” Investment Committee debate the biggest analyst calls of the day.
Eli Lilly Stock's Upside Prompts Morgan Stanley to Ask if It Can Reach $1 Trillion
12:53pm, Friday, 16'th Feb 2024
Morgan Stanley analyst Terence Flynn increases his price target on shares of the drugmaker to $950 from $805.
My Top 3 Stock Candidates to Replace Tesla in the Magnificent 7
12:13pm, Friday, 16'th Feb 2024
A year ago, we wouldn't discuss replacing Tesla (NASDAQ: TSLA ) as one of the Magnificent 7 stocks. However, losing 50% of its value since November, the drum beat gets louder to replace Elon Musk's ba
S&P 500's surge to new highs: Bull trap hiding in plain sight?
09:40am, Thursday, 15'th Feb 2024
The SPDR S&P 500 ETF Trust NYSEARCA: SPY is trading at new highs, but as the sharp pullback on February 13 showed, the rally may be showing signs of cracking.
Tiger Global slashes stakes in Magnificent Seven while piling into semiconductor makers
05:06am, Thursday, 15'th Feb 2024
Tiger Global has slashed its positions in four of the five Magnificent Seven tech stocks that account for almost half of its portfolio, while upping its stake in Amazon.com and piling into semiconduct
7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution
02:43pm, Wednesday, 14'th Feb 2024
It is entirely fair to state that weight loss treatments have massive transformational power. US FDA approval of weight loss medicines could help shrink millions of waistlines.
Amgen Takes Aim at Novo Nordisk and Eli Lilly, but Is the Stock a Buy?
02:59am, Wednesday, 14'th Feb 2024
Amgen is the latest big pharma to join the gold rush to treat obesity. Its candidate is distinct from the medicines by Eli Lilly and Novo Nordisk.
Eli Lilly's weight-loss drug could be the best selling drug of all time, says Jim Cramer
08:36pm, Tuesday, 13'th Feb 2024
'Mad Money' host Jim Cramer looks at the top performing stocks on the S&P 500 as it reached the 5,000 milestone.
